Log in

NASDAQ:SUPNSupernus Pharmaceuticals News Headlines

$22.81
-0.22 (-0.96 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$22.47
Now: $22.81
$24.15
50-Day Range
$22.26
MA: $23.52
$24.94
52-Week Range
$13.12
Now: $22.81
$29.81
Volume1.13 million shs
Average Volume559,512 shs
Market Capitalization$1.20 billion
P/E Ratio10.51
Dividend YieldN/A
Beta1.55

Headlines

Supernus Pharmaceuticals (NASDAQ SUPN) News Headlines

Source:
DateHeadline
Supernus Pharmaceuticals (NASDAQ:SUPN) Rating Lowered to Strong Sell at BidaskClubSupernus Pharmaceuticals (NASDAQ:SUPN) Rating Lowered to Strong Sell at BidaskClub
marketbeat.com - August 7 at 7:15 AM
Supernus Announces Preliminary Second Quarter 2020 RevenueSupernus Announces Preliminary Second Quarter 2020 Revenue
finance.yahoo.com - August 11 at 5:29 PM
Is a Surprise Coming for Supernus (SUPN) This Earnings Season?Is a Surprise Coming for Supernus (SUPN) This Earnings Season?
finance.yahoo.com - August 10 at 1:58 PM
Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Receives Consensus Recommendation of "Hold" from AnalystsSupernus Pharmaceuticals Inc (NASDAQ:SUPN) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 2 at 8:02 AM
Supernus Pharmaceuticals (NASDAQ:SUPN)  Shares Down 5.3% Supernus Pharmaceuticals (NASDAQ:SUPN) Shares Down 5.3%
www.americanbankingnews.com - July 31 at 8:19 PM
Will Supernus (SUPN) Beat Estimates Again in Its Next Earnings Report?Will Supernus (SUPN) Beat Estimates Again in Its Next Earnings Report?
finance.yahoo.com - July 30 at 1:40 PM
Earnings Preview: Supernus Pharmaceuticals (SUPN) Q2 Earnings Expected to DeclineEarnings Preview: Supernus Pharmaceuticals (SUPN) Q2 Earnings Expected to Decline
finance.yahoo.com - July 28 at 6:06 PM
$88.08 Million in Sales Expected for Supernus Pharmaceuticals Inc (NASDAQ:SUPN) This Quarter$88.08 Million in Sales Expected for Supernus Pharmaceuticals Inc (NASDAQ:SUPN) This Quarter
www.americanbankingnews.com - July 25 at 4:42 AM
Zacks: Brokerages Expect Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Will Post Earnings of $0.35 Per ShareZacks: Brokerages Expect Supernus Pharmaceuticals Inc (NASDAQ:SUPN) Will Post Earnings of $0.35 Per Share
www.americanbankingnews.com - July 23 at 5:42 AM
Supernus Sues Apotex for Infringement of Oxtellar XR® PatentsSupernus Sues Apotex for Infringement of Oxtellar XR® Patents
finance.yahoo.com - July 4 at 8:00 AM
Four reasons why the Supernus Pharmaceuticals Inc (NMQ:SUPN) share price could moveFour reasons why the Supernus Pharmaceuticals Inc (NMQ:SUPN) share price could move
uk.finance.yahoo.com - June 18 at 1:06 PM
Supernus Pharmaceuticals Inc (SUPN): Hedge Funds Are Snapping UpSupernus Pharmaceuticals Inc (SUPN): Hedge Funds Are Snapping Up
finance.yahoo.com - June 18 at 1:06 PM
Supernus Makeover: A Work In ProgressSupernus' Makeover: A Work In Progress
seekingalpha.com - June 16 at 1:28 PM
Supernus Completes Acquisition of CNS Portfolio from US WorldMedsSupernus Completes Acquisition of CNS Portfolio from US WorldMeds
finance.yahoo.com - June 9 at 7:52 PM
Supernus to Present at the Jefferies Virtual Health Care ConferenceSupernus to Present at the Jefferies Virtual Health Care Conference
finance.yahoo.com - May 27 at 7:31 PM
Supernus Offers Strong Value In The CNS SpaceSupernus Offers Strong Value In The CNS Space
seekingalpha.com - May 25 at 7:01 AM
Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR®Supernus Announces Paragraph IV ANDA Filing for Oxtellar XR®
finance.yahoo.com - May 15 at 5:53 PM
Were Hedge Funds Right About Supernus Pharmaceuticals Inc (SUPN)?Were Hedge Funds Right About Supernus Pharmaceuticals Inc (SUPN)?
finance.yahoo.com - May 9 at 5:46 PM
Supernus Pharmaceuticals Inc (SUPN) Q1 2020 Earnings Call TranscriptSupernus Pharmaceuticals Inc (SUPN) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 9:33 PM
Edited Transcript of SUPN earnings conference call or presentation 6-May-20 1:00pm GMTEdited Transcript of SUPN earnings conference call or presentation 6-May-20 1:00pm GMT
finance.yahoo.com - May 7 at 4:33 PM
Supernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2020 Results - Earnings Call TranscriptSupernus Pharmaceuticals, Inc. (SUPN) CEO Jack Khattar on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 6 at 3:19 PM
Supernus Announces First Quarter 2020 Financial ResultsSupernus Announces First Quarter 2020 Financial Results
finance.yahoo.com - May 6 at 12:18 AM
Supernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Top EstimatesSupernus Pharmaceuticals (SUPN) Q1 Earnings and Revenues Top Estimates
finance.yahoo.com - May 6 at 12:18 AM
Supernus Pharmaceuticals EPS beats by $0.13, beats on revenueSupernus Pharmaceuticals EPS beats by $0.13, beats on revenue
seekingalpha.com - May 5 at 8:21 PM
Supernus Pharmaceuticals Q1 2020 Earnings PreviewSupernus Pharmaceuticals Q1 2020 Earnings Preview
seekingalpha.com - May 4 at 8:59 PM
How Does Supernus Pharmaceuticals's (NASDAQ:SUPN) P/E Compare To Its Industry, After Its Big Share Price Gain?How Does Supernus Pharmaceuticals's (NASDAQ:SUPN) P/E Compare To Its Industry, After Its Big Share Price Gain?
finance.yahoo.com - May 2 at 4:40 AM
How Does Supernus Pharmaceuticalss (NASDAQ:SUPN) P/E Compare To Its Industry, After Its Big Share Price Gain?How Does Supernus Pharmaceuticals's (NASDAQ:SUPN) P/E Compare To Its Industry, After Its Big Share Price Gain?
finance.yahoo.com - May 1 at 7:36 AM
Louisville pharma company lands $530M saleLouisville pharma company lands $530M sale
www.bizjournals.com - April 30 at 4:35 PM
A Super Pick-Up By SupernusA Super 'Pick-Up' By Supernus
seekingalpha.com - April 30 at 4:35 PM
Supernus buys CNS portfolio for $530MSupernus buys CNS portfolio for $530M
seekingalpha.com - April 28 at 7:17 PM
Supernus to Acquire CNS Portfolio from US WorldMedsSupernus to Acquire CNS Portfolio from US WorldMeds
finance.yahoo.com - April 28 at 7:17 PM
Supernus Pharmaceuticals Inc.Supernus Pharmaceuticals Inc.
www.marketwatch.com - April 25 at 11:01 PM
Supernus to Host First Quarter Results Earnings Conference CallSupernus to Host First Quarter Results Earnings Conference Call
finance.yahoo.com - April 24 at 6:51 PM
Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138Supernus and Navitor Announce Development and Option Agreement for Orally Active mTORC1 Activator NV-5138
finance.yahoo.com - April 21 at 6:26 PM
Supernus Pharmaceuticals (NASDAQ:SUPN) Seems To Use Debt Quite SensiblySupernus Pharmaceuticals (NASDAQ:SUPN) Seems To Use Debt Quite Sensibly
finance.yahoo.com - April 15 at 3:37 PM
Supernus Provides Business UpdateSupernus Provides Business Update
finance.yahoo.com - March 30 at 8:21 PM
Supernus PharmaceuticalsSupernus Pharmaceuticals
www.fool.com - March 29 at 11:17 PM
Need To Know: Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Insiders Have Been Buying SharesNeed To Know: Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Insiders Have Been Buying Shares
finance.yahoo.com - March 16 at 3:10 PM
Edited Transcript of SUPN earnings conference call or presentation 26-Feb-20 2:00pm GMTEdited Transcript of SUPN earnings conference call or presentation 26-Feb-20 2:00pm GMT
finance.yahoo.com - March 13 at 12:32 AM
Supernus Pharmaceuticals Enters Oversold Territory (SUPN)Supernus Pharmaceuticals Enters Oversold Territory (SUPN)
www.nasdaq.com - February 28 at 8:29 AM
Why Supernus Pharmaceuticals Plunged 15% TodayWhy Supernus Pharmaceuticals Plunged 15% Today
www.fool.com - February 26 at 6:52 PM
Supernus to Present at the 2020 Cowen Health Care ConferenceSupernus to Present at the 2020 Cowen Health Care Conference
finance.yahoo.com - February 26 at 5:09 PM
Supernus Pharmaceuticals Inc (SUPN) Q4 2019 Earnings Call TranscriptSupernus Pharmaceuticals Inc (SUPN) Q4 2019 Earnings Call Transcript
www.fool.com - February 26 at 2:31 PM
Supernus: 4Q Earnings SnapshotSupernus: 4Q Earnings Snapshot
finance.yahoo.com - February 25 at 8:25 PM
Supernus Pharmas SPN-810 trial did not meet primary endpointSupernus Pharma's SPN-810 trial did not meet primary endpoint
seekingalpha.com - February 25 at 8:25 PM
Supernus Pharmaceuticals EPS beats by $0.04, misses on revenueSupernus Pharmaceuticals EPS beats by $0.04, misses on revenue
seekingalpha.com - February 25 at 8:25 PM
Supernus Announces Fourth Quarter and Full Year 2019 Financial ResultsSupernus Announces Fourth Quarter and Full Year 2019 Financial Results
finance.yahoo.com - February 25 at 8:25 PM
Supernus Pharmaceuticals (SUPN) Q4 Earnings Beat EstimatesSupernus Pharmaceuticals (SUPN) Q4 Earnings Beat Estimates
finance.yahoo.com - February 25 at 8:25 PM
Supernus Pharmaceuticals, Inc. (SUPN)Supernus Pharmaceuticals, Inc. (SUPN)
finance.yahoo.com - February 25 at 3:25 PM
Supernus Pharmaceuticals Q4 2019 Earnings PreviewSupernus Pharmaceuticals Q4 2019 Earnings Preview
seekingalpha.com - February 24 at 6:26 PM
Supernus Pharmaceuticals, Inc. Common Stock (SUPN) Option ChainSupernus Pharmaceuticals, Inc. Common Stock (SUPN) Option Chain
www.nasdaq.com - February 22 at 11:14 PM
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.